Immunovia AB (OTC: IMMVF) Starts Presentation at The LD 500
Immunovia AB (OTC: IMMVF) is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia's proprietary test platform called IMMray(TM), an antibody-based multiplex test that is designed to provide a snapshot of the immune system response based on the information available in a single drop of blood. IMMray is more than a technology; it is a systematic approach, based on cutting-edge bioinformatics, to finding the most clinically relevant changes that appear in the blood and combining this knowledge into a 'disease fingerprint' – also called a…







